Skip to content
ppharmaranks
Menu
Class IIOngoing

Fluticasone Propionate Nasal Spray USP 50mcg recall

FDA recall D-0326-2024 · initiated Feb 9, 2024

By the pharmaranks editorial teamReviewed against the FDA (openFDA) sourcesUpdated Feb 28, 2024How we research

Apotex Corp. recalled Fluticasone Propionate Nasal Spray USP 50mcg in Feb 2024 — an FDA Class II recall (D-0326-2024) because CGMP Deviations: potential presence of Burkholderia cepacia complex.

May cause temporary or medically reversible harm; low probability of serious harm.

Why it was recalled

CGMP Deviations: potential presence of Burkholderia cepacia complex

The manufacturing process itself

The FDA found the process itself out of compliance, usually before any defective product was identified.

This is a manufacturing or quality failure, not a finding that the medicine is unsafe to take — across every recall we hold, none was issued for that reason. It does not mean the batch was harmless.

Is your product affected? Check the lot number

A recall covers only specific lots. Find the lot number and expiration date on your package and compare them to the affected codes below — if yours is not listed, it was not part of this recall.

Lot number # TX5274 Exp. 09/30/2026

Quantity recalled: 292,752 bottles

Details

Product
Fluticasone Propionate Nasal Spray USP 50mcg, 120 Metered Sprays - 16 g net fill, Rx Only, Manufactured by: Apotex Inc. Toronto, Ontario Canada M9L 1T9, Manufactured for: Apotex Corp Weston, FL 33326. NDC 60505-0829-1
Recalling company
Apotex
Classification
Class II
Status
Ongoing
Type
Voluntary: Firm initiated
Distribution
Nationwide in the USA
Initiated
Feb 9, 2024
FDA report date
Feb 28, 2024
What to do.If you have a recalled product, don't throw away questions — check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This page reproduces public FDA data and is not medical advice.

Frequently asked

Was Fluticasone Propionate Nasal Spray USP 50mcg recalled?
Apotex Corp. recalled Fluticasone Propionate Nasal Spray USP 50mcg in Feb 2024 — an FDA Class II recall (D-0326-2024) because CGMP Deviations: potential presence of Burkholderia cepacia complex. May cause temporary or medically reversible harm; low probability of serious harm.
Why was Fluticasone Propionate Nasal Spray USP 50mcg recalled?
Per the FDA enforcement record, the reason for recall D-0326-2024 was: CGMP Deviations: potential presence of Burkholderia cepacia complex
Is a recalled Fluticasone Propionate Nasal Spray USP 50mcg dangerous to take?
An FDA recall removes specific lots from the market for a defined reason and does not by itself mean the medicine is unsafe for everyone — your specific lot may never have been affected. May cause temporary or medically reversible harm; low probability of serious harm. Check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This reproduces public FDA data and is not medical advice.
Which lots of Fluticasone Propionate Nasal Spray USP 50mcg are affected?
Distributed: Nationwide in the USA. The recall covers these lots — Lot number # TX5274 Exp. 09/30/2026. Check the lot number and expiration date on your package against this list; if yours is not listed, it was not part of recall D-0326-2024.

Source: openFDA Drug Enforcement record D-0326-2024

← All drug recalls